1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-
|
|
1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- 속성
- 녹는점
- 216-217°C
- 밀도
- 1.50±0.1 g/cm3(Predicted)
- 저장 조건
- -20°C Freezer, Under inert atmosphere
- 용해도
- 아세트산에틸 (약간 용해됨), 메탄올 (약간 용해됨)
- 산도 계수 (pKa)
- 11.69±0.50(Predicted)
- 물리적 상태
- 고체
- 물리적 상태
- 단단한 모양
- 색상
- 흰색에서 황백색까지
- 안정성
- 솔루션이 불안정함
안전
1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- C화학적 특성, 용도, 생산
용도
Ruxolitinib-amide is an impurity of Ruxolitinib. Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- 준비 용품 및 원자재
원자재
준비 용품
1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- 공급 업체
글로벌( 16)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
ShenZhen H&D Pharmaceutical Technology Co., LTD | +86-0755-22677845 +86-13627253706 |
sale@hdimpurity.com | China | 3095 | 58 |
Shanghai Kewel Chemical Co., Ltd. | 021-64609169 18901607656 |
greensnown@163.com | China | 9911 | 50 |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 8255 | 55 |
Hefei fuya biotechnology co. LTD | 18096409024 |
sales02@foreversyn.com | China | 1973 | 58 |
Hubei Ruinuo Pharmaceutical Technology Co., Ltd | 13165688766 |
3008058303@qq.com | China | 5000 | 58 |
Jiangsu Wansipu Technology Co., Ltd. | 17826022701 |
1485609990@qq.com | China | 924 | 58 |
QUALITY CONTROL SOLUTIONS LTD. | 13670046396 |
ORDERS@QCSRM.COM | China | 18865 | 58 |
Molcoo Chemicals Inc. | 18627923403 18627753421 |
3001006472@qq.com | China | 9161 | 58 |
Shenzhen Roark Pharma-Tec Co., Ltd. | 13128912434 |
2880126944@qq.com | China | 2579 | 58 |
Cato Research Chemicals Inc. | 020-81960175-877 18933936954 |
tianwen.zhan@cato-chem.com | China | 7721 | 58 |
1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- 관련 검색:
3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
S-Ruxolitinib (INCB018424)
4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(triMethylsilyl)ethoxy]Methyl]-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-
1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-
1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)-
1H-Pyrazole-1-propanenitrile, β-(2-hydroxycyclopentyl)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-
1H-Pyrazole-1-propanenitrile, 4-(6-amino-5-formyl-4-pyrimidinyl)-β-cyclopentyl-, (βR)-